Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(IV) : 삶의 질
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 민경준 | - |
| dc.contributor.author | 전덕인 | - |
| dc.contributor.author | 신영철 | - |
| dc.contributor.author | 김찬형 | - |
| dc.contributor.author | 윤보현 | - |
| dc.contributor.author | 조현상 | - |
| dc.contributor.author | 권준수 | - |
| dc.contributor.author | 박원명 | - |
| dc.date.available | 2019-07-18T04:58:32Z | - |
| dc.date.issued | 2005 | - |
| dc.identifier.issn | 1017-5717 | - |
| dc.identifier.issn | 2092-5700 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/29533 | - |
| dc.format.extent | 10 | - |
| dc.publisher | 대한정신약물학회 | - |
| dc.title | 한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(IV) : 삶의 질 | - |
| dc.title.alternative | Feasibility of Korean Medication Algorithm for Bipolar Disorder(IV): Quality of Life | - |
| dc.type | Article | - |
| dc.identifier.bibliographicCitation | 대한정신약물학회지, v.16, no.5, pp 396 - 405 | - |
| dc.identifier.kciid | ART001145934 | - |
| dc.description.isOpenAccess | N | - |
| dc.citation.endPage | 405 | - |
| dc.citation.number | 5 | - |
| dc.citation.startPage | 396 | - |
| dc.citation.title | 대한정신약물학회지 | - |
| dc.citation.volume | 16 | - |
| dc.publisher.location | 대한민국 | - |
| dc.subject.keywordAuthor | 양극성 장애 | - |
| dc.subject.keywordAuthor | 한국형 약물치료 알고리듬 | - |
| dc.subject.keywordAuthor | 적용 가능성 | - |
| dc.subject.keywordAuthor | 삶의 질 | - |
| dc.subject.keywordAuthor | Bipolar disorder | - |
| dc.subject.keywordAuthor | Korean medication algorithm | - |
| dc.subject.keywordAuthor | Feasibility | - |
| dc.subject.keywordAuthor | Quality of life | - |
| dc.subject.keywordAuthor | WHOQOL-BREF | - |
| dc.description.journalRegisteredClass | kci | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.